Immuron Limited (IMRN)
NASDAQ: IMRN · Real-Time Price · USD
1.510
-0.220 (-12.72%)
At close: Nov 5, 2025, 4:00 PM EST
1.520
+0.010 (0.66%)
Pre-market: Nov 6, 2025, 6:25 AM EST
Immuron Market Cap
Immuron has a market cap or net worth of $11.9 million as of November 6, 2025. Its market cap has increased by 6.25% in one year.
Market Cap
11.90M
Enterprise Value
8.16M
1-Year Change
6.25%
Ranking
Category
Stock Price
$1.51
Market Cap Chart
Since June 9, 2017, Immuron's market cap has decreased from $28.10M to $11.90M, a decrease of -57.65%. That is a compound annual growth rate of -9.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 5, 2025 | 8.80M | -9.28% |
| Dec 31, 2024 | 9.70M | -9.35% |
| Dec 29, 2023 | 10.70M | -9.32% |
| Dec 30, 2022 | 11.80M | -16.90% |
| Dec 31, 2021 | 14.20M | -50.00% |
| Dec 31, 2020 | 28.40M | 91.89% |
| Dec 31, 2019 | 14.80M | -28.50% |
| Dec 31, 2018 | 20.70M | 20.35% |
| Dec 29, 2017 | 17.20M | -38.79% |
| Jun 9, 2017 | 28.10M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 772.59B |
| Johnson & Johnson | 455.04B |
| AbbVie | 385.18B |
| UnitedHealth Group | 309.40B |
| AstraZeneca | 253.98B |
| Novartis AG | 237.13B |
| Novo Nordisk | 216.87B |
| Abbott Laboratories | 214.96B |